gastric-cancer

Documents about gastric-cancer

• Intraperitoneal Paclitaxel With XELOX in Gastric Cancer With Peritoneal Metastasis#909653ClinicalTrials.gov
• A Study Of Avelumab In Combination With Other Cancer Immunotherapies In Advanced Malignancies (JAVELIN Medley)#880294ClinicalTrials.gov
• Development of 3D spheroids of AGS gastric cancer cells in vitro for exploration of H. pylori influence on tumor environment and anti-cancer activity of PLA-His-DOX nanoparticles.#671258NCBI PubMed Central
• A Phase II Clinical Study Evaluating SSGJ-706 in Combination Therapy for Advanced Gastrointestinal Cancers#858858ClinicalTrials.gov
• Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial#829862ClinicalTrials.gov
• Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)#238110ClinicalTrials.gov
• PF-07265028 As Single Agent And In Combination With Sasanlimab in Advanced or Metastatic Solid Tumors#905590ClinicalTrials.gov
• Data Sheet 1_Tumor-intrinsic immune-genetic dynamics identify RNASE1 as an immune-evasion-associated biomarker and predictor of checkpoint blockade response in gastric adenocarcinoma.docx#322249Figshare
• Disitamab Vedotin Combined With SOX Regimen Versus SOX Alone as Adjuvant Therapy for HER2-Moderate/High Expressing Stage Ⅲ Gastric Cancer: A Prospective, Multicenter, Randomized, Phase Ⅱ Clinical Trial#834171ClinicalTrials.gov
• Phase III Open-labeled Study of NPO-11 in Patients Undergoing Therapeutic Upper Gastrointestinal Endoscopy#850094ClinicalTrials.gov
• Combined analysis of chromatin accessibility, promoter interactions and whole genome sequencing solved the missing heritability in gastric cancer#127879bioRxiv / medRxiv
• Single-cell atlas of gastric cancer reveals malignant epithelial evolution and regulatory reprogramming of the tumor microenvironment#130385Unpaywall
• Combined analysis of chromatin accessibility, promoter interactions and whole genome sequencing solved the missing heritability in gastric cancer#132267Unpaywall
• FGFR2 and favorable survival outcomes in resected poorly cohesive cell gastric cancer: Analysis from FGFR2 protein overexpression and genetic variation.#251131NCBI PubMed Central
• Gene-guided repurposing identifies dihydroergotamine as a candidate inhibitor of the BCL2-SIVA1 axis in advanced gastric cancer in vitro.#251181NCBI PubMed Central
• Predictive value of the preoperative systemic immune-inflammation index for primary chemotherapy resistance risk in patients with advanced gastric cancer.#368067NCBI PubMed Central
• N-Doped carbon quantum dot-based ratiometric fluorescent nanosensor platforms for detection of gastric cancer-associated <i>Helicobacter pylori</i> genes#419897Aperta
• 3D Versus 2D Laparoscopic Total Gastrectomy With Splenic Hilum Lymph Nodes Dissection#828752ClinicalTrials.gov
• Helicobacter Pylori Screening and Treatment in the At-risk South Florida Community-AIM 2#829079ClinicalTrials.gov
• Patient-Derived Xenografts to Reduce Cancer Health Disparities#846245ClinicalTrials.gov
• The Anti-reflux Effect of Double-flap Technique in Laparoscopic Proximal Gastrectomy.#846940ClinicalTrials.gov
• Clinical Study of CLDN18.2 PET/CT for Noninvasive Diagnosis of Gastric and Pancreatic Cancer#854567ClinicalTrials.gov
• Clinical Outcomes of Laparoscopic D1 Versus D2 Lymphadenectomy for Elderly Patients With Advanced Gastric Cancer#903397ClinicalTrials.gov
• A Phase II Study of Postoperative S-1-Based Chemoradiotherapy in Gastric Cancer#903836ClinicalTrials.gov
• Dynamic Neutrophil-to-Lymphocyte Ratio Stratifies Survival and Immune-Related Adverse Events in Lung and Gastric Cancer Patients with Immunotherapy.#923376NCBI PubMed Central
• Evaluating the Safety and Tolerability of the Poly-ADP Ribose (PARP) Inhibitor With FOLFIRI in Subjects With Solid Tumor#969882ClinicalTrials.gov
• Monitored Anesthesia Care With Propofol Plus Remifentanil During Endoscopic Submucosal Dissection: Evaluation of Bispectral Index Monitoring#992431ClinicalTrials.gov
• Exposure-response relationship of sintilimab in advanced gastric cancer: insights from time-dependent pharmacokinetics and biomarker integration for precision immunotherapy.#1001076NCBI PubMed Central
• A Study of NX-1607 in Adults With Advanced Malignancies#879199ClinicalTrials.gov
• The w-eCura system is a novel indicator of the need for salvage surgery after non-curable endoscopic submucosal dissection in early gastric cancer: A retrospective case-controlled study#203139PLOS
• A Phase Ib Trial Evaluating the Safety and Activity of Neoadjuvant Combination of Tislelizumab Plus FLOT for Resectable Esophagogastric Adenocarcinoma#892009ClinicalTrials.gov
• A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants with Advanced Unresectable or Metastatic Solid Tumors#252982ClinicalTrials.gov
• Suelos contaminados con metales pesados y riesgo de cáncer gástrico Perspectivas moleculares y la relevancia de una perspectiva de «One Health»#323707Repositorio de la Pontificia Universidad Católica del Ecuador
• A Phase I Study to Evaluate the Safety,Pharmacokinetics,Pharmacodynamics,and Efficacy of TJ037130 in Adult Participants With Advanced Solid Tumors#1007870ClinicalTrials.gov
• Molecular and structural reprogramming of gastric cancer revealed by systems-level transcriptomic analysis#214335PLOS
• Analysis of the efficacy and mechanism of action of Buzhong Yiqi Decoction on gastric cancer using meta-analysis and network pharmacology.#251275NCBI PubMed Central
• Systematic pan-cancer analysis reveals context-dependent prognostic and immunological roles of WDR1 with divergent effects in renal and gastric cancers.#371521NCBI PubMed Central
• Benefit of Linked-Color Imaging in Artificial Intelligence-Assisted Diagnosis of Early Gastric Cancer: A Pilot Study With Propensity Score Adjustment.#412229NCBI PubMed Central
• Efficacy hierarchy and absolute survival benefit of first-line immunotherapy in advanced gastric cancer: a meta-analysis and pooled survival analysis.#630984NCBI PubMed Central
• A Study of Ramucirumab (LY3009806) in Combination With Capecitabine and Cisplatin in Participants With Stomach Cancer#802646ClinicalTrials.gov
• Phase I Study of Interperitoneal Chenotherapy in Patients With Gastric Adenocarainoma With Peritoneal Seeding#900665ClinicalTrials.gov
• Gastroesophageal reflux disease and the relationship with Helicobacter pylori#954943Koc University Digital Collections
• A Phase 1/2, Open-label, Multi-center Study of the Safety and Efficacy of Alomfilimab (KY1044) as Single Agent and in Combination With Anti-PD-L1 (Atezolizumab) in Adult Patients With Selected Advanced Malignancies#830569ClinicalTrials.gov
• Ph 1-2 Study ADI-PEG 20 Plus FOLFOX in Subjects With Advanced GI Malignancies Focusing on Hepatocellular Carcinoma#803526ClinicalTrials.gov
• A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors#911909ClinicalTrials.gov
• LncRNA NEAT1 promotes immunosuppression in gastric cancer under endoplasmic reticulum stress by maintaining the M(6)A methylation of SEMA3A in CAFs.#3954NCBI PubMed Central
• Deciphering IFN signaling in gastric cancer: A single-cell and bulk transcriptomic integration reveals CXCR4 as a key immunomodulator and prognostic determinant.#143193NCBI PubMed Central
• The Clinical Impact of Textbook Outcome in Patients With Stage 1 Gastric Cancer Who Received Laparoscopy-assisted Gastrectomy or Robotic-assisted Gastrectomy.#154278NCBI PubMed Central
• Application of artificial intelligence based on contrast-enhanced CT imaging for predicting peritoneal metastasis in patients with T3/T4 stage gastric cancer.#189943NCBI PubMed Central
• Predicting response to neoadjuvant chemotherapy combined with immunotherapy in gastric cancer based on habitat imaging and peritumoral radiomics: a two-center study.#236081NCBI PubMed Central